GO:0061931 positive regulation of erythrocyte enucleation: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061931 describes any process that increases the frequency, rate or extent of erythrocyte enucleation, the final step in red blood cell maturation.
• Enucleation is a hallmark of terminal erythropoiesis and is tightly linked to cell-cycle exit and nuclear condensation.
• The miR-144/451 cluster promotes erythroid differentiation by inhibiting c-Myc, thereby supporting enucleation.
• Down-regulation of Myc is essential for terminal erythroid maturation, including enucleation.
• Erythroblastic islands provide a specialized niche that supports terminal erythropoiesis and enucleation.
• SMIM1 missense mutations affect Vel expression late in erythroid differentiation, a stage that includes enucleation.
Description
Erythrocyte enucleation is the process by which a late-stage erythroblast expels its nucleus to become a mature red blood cell. GO:0061931, positive regulation of erythrocyte enucleation, refers to any process that increases the frequency, rate or extent of this enucleation event. This term is a biological process annotation that captures the positive control of a terminal step in erythropoiesis, and it is essential for understanding how red blood cell production is regulated under normal and pathological conditions. Researchers study this term because defects in enucleation contribute to ineffective erythropoiesis, and because enucleation is a prerequisite for the deformable, hemoglobin-filled erythrocyte that circulates in blood. The process is coordinated with cell-cycle exit, nuclear condensation, and cytoskeletal remodeling, and it is influenced by extracellular signals and niche interactions. Positive regulators of enucleation include microRNAs and transcription factors that suppress stemness and proliferation programs, such as the miR-144/451 cluster and the down-regulation of c-Myc. Understanding GO:0061931 therefore provides a framework for studying how erythroid progenitors commit to terminal maturation and how this commitment can be enhanced or disrupted in disease.
positive regulation of erythrocyte enucleation At A Glance
| GO ID | GO:0061931 |
|---|---|
| GO term | positive regulation of erythrocyte enucleation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Positive regulation of the frequency, rate or extent of erythrocyte enucleation |
| Related process | Terminal erythropoiesis and erythroblast maturation |
| Key regulators | miR-144/451, c-Myc, and niche-derived signals |
| Disease relevance | Ineffective erythropoiesis and erythroid disorders |
| Research methods | CRISPR knockout, overexpression, RNA-seq, imaging |
What Is GO:0061931?
GO:0061931 is defined as any process that increases the frequency, rate or extent of erythrocyte enucleation. In other words, it covers the positive regulatory inputs that promote the expulsion of the nucleus from an erythroblast during terminal erythropoiesis. This is a biological process term, and it is the positive-regulation counterpart of the enucleation process itself. The term does not describe the structural components of the nucleus or the mechanics of enucleation per se, but rather the upstream and concurrent signals that enhance the likelihood or efficiency of enucleation.
Why Is positive regulation of erythrocyte enucleation Important in Cell Biology?
Positive regulation of erythrocyte enucleation is important because enucleation is the defining terminal event of erythropoiesis, and its dysregulation leads to ineffective red blood cell production. The process is coordinated with cell-cycle exit and nuclear condensation, and positive regulators such as the miR-144/451 cluster and c-Myc down-regulation are required for terminal erythroid maturation. Erythroblastic islands provide a niche that supports this maturation step, and disruptions in niche interactions can impair enucleation. Understanding GO:0061931 therefore has direct implications for red blood cell disorders, for the production of cultured red blood cells, and for basic research on cell differentiation and nuclear expulsion.
• Enucleation is required for the formation of mature, deformable red blood cells.
• Positive regulation of enucleation is linked to cell-cycle exit and terminal differentiation.
• The miR-144/451 cluster promotes erythroid differentiation by inhibiting c-Myc, supporting enucleation.
• Down-regulation of Myc is essential for terminal erythroid maturation, including enucleation.
• Erythroblastic islands provide a niche that supports terminal erythropoiesis and enucleation.
• SMIM1 missense mutations affect Vel expression late in erythroid differentiation, a stage that includes enucleation.
• Steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors.
• Beta-adrenergic mechanisms regulate early and late erythropoiesis, including terminal maturation.
• Cultured red blood cell production depends on efficient enucleation for translational applications.
• Defects in enucleation contribute to ineffective erythropoiesis in hematological disease.
What Happens During positive regulation of erythrocyte enucleation?
Cell-cycle exit and nuclear condensation
In simple terms: The cell stops dividing and its nucleus becomes compact before being pushed out.
Positive regulation of erythrocyte enucleation begins with the coordination of cell-cycle exit and nuclear condensation. Down-regulation of Myc is essential for terminal erythroid maturation, and this down-regulation is a prerequisite for the nuclear changes that precede enucleation. The miR-144/451 cluster contributes to this step by inhibiting c-Myc, thereby promoting erythroid differentiation. These events ensure that the erythroblast is poised to expel its nucleus rather than continue proliferating.
Niche interactions and erythroblastic islands
In simple terms: The cell receives supportive signals from its surrounding environment in the bone marrow.
Erythroblastic islands are specialized niches for erythropoiesis, and they provide support for terminal maturation, including enucleation. Positive regulation of enucleation can therefore be influenced by adhesion and signaling interactions within these islands. Disruption of niche interactions may impair the efficiency of enucleation, linking the process to the broader regulation of erythropoiesis.
MicroRNA-mediated control
In simple terms: Small RNA molecules fine-tune the genes that control red blood cell maturation.
The miR-144/451 cluster inhibits c-Myc to promote erythroid differentiation, which supports the positive regulation of enucleation. This microRNA-mediated control provides a layer of post-transcriptional regulation that ensures timely down-regulation of proliferation-associated genes. The loss of this regulation can delay or impair terminal maturation, highlighting its importance in enucleation.
Steroid and adrenergic modulation
In simple terms: Hormones and stress signals can influence how red blood cells mature.
Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors, indicating that steroid signals can modulate the balance between proliferation and maturation. Discrete beta-adrenergic mechanisms regulate early and late erythropoiesis, including terminal stages. These extracellular signals can therefore contribute to the positive regulation of enucleation by favoring terminal differentiation.
Late-stage differentiation and Vel expression
In simple terms: Some markers appear late in red blood cell development and can affect the final steps.
SMIM1 missense mutations exert their effect on wild type Vel expression late in erythroid differentiation, a stage that includes enucleation. This suggests that late-stage differentiation events can influence the efficiency of terminal maturation. Studying such late markers helps define the window during which positive regulation of enucleation is most critical.
Key Genes Involved in GO:0061931 positive regulation of erythrocyte enucleation
The following genes and proteins are involved in the positive regulation of erythrocyte enucleation or in the terminal erythropoiesis context in which this process occurs.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYC | Down-regulation is essential for terminal erythroid maturation | Key target for studying enucleation control |
| miR-144/451 | Inhibits c-Myc to promote erythroid differentiation | MicroRNA-mediated regulation of enucleation |
| SMIM1 | Affects Vel expression late in erythroid differentiation | Late-stage differentiation marker |
| GATA1 | Erythroid transcription factor | Terminal erythropoiesis regulation |
| KLF1 | Erythroid transcription factor | Terminal erythropoiesis regulation |
| EPOR | Erythropoietin receptor | Erythropoiesis signaling |
| TAL1 | Erythroid transcription factor | Terminal erythropoiesis regulation |
| LMO2 | Erythroid transcription factor | Terminal erythropoiesis regulation |
| BCL11A | Repressor of fetal hemoglobin | Erythroid maturation regulation |
| c-KIT | Stem cell factor receptor | Early erythropoiesis signaling |
| ITGA4 | Integrin alpha 4 | Erythroblastic island adhesion |
| ITGB1 | Integrin beta 1 | Erythroblastic island adhesion |
| VCAM1 | Adhesion molecule on macrophages | Erythroblastic island niche |
| EMP | Erythroblast macrophage protein | Erythroblastic island interaction |
| SPI1 | Macrophage transcription factor | Niche support for erythropoiesis |
| HBB | Beta-globin | Erythroid maturation marker |
| HBA1 | Alpha-globin | Erythroid maturation marker |
| SLC4A1 | Band 3 anion transporter | Late erythroid differentiation |
How Is positive regulation of erythrocyte enucleation Regulated?
Positive regulation of erythrocyte enucleation is controlled by a combination of transcriptional, post-transcriptional, and extracellular signals. The miR-144/451 cluster inhibits c-Myc to promote erythroid differentiation, and down-regulation of Myc is essential for terminal erythroid maturation. Erythroblastic islands provide niche-derived signals that support terminal erythropoiesis, including enucleation. Steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors, and beta-adrenergic mechanisms regulate early and late erythropoiesis. These layers of regulation ensure that enucleation occurs at the appropriate stage of erythroid maturation.
positive regulation of erythrocyte enucleation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYC | Ineffective erythropoiesis | MYC knockout in erythroid progenitors |
| miR-144/451 | Erythroid differentiation defects | miR-144/451 overexpression |
| SMIM1 | Vel-negative phenotype | SMIM1 point mutation |
| EPOR | Erythropoietin-resistant anemia | EPOR knockout |
| GATA1 | Erythroid maturation arrest | GATA1 knockout |
Ineffective erythropoiesis and erythroid disorders
Defects in terminal erythroid maturation, including enucleation, contribute to ineffective erythropoiesis. The erythroblastic island niche is essential for normal erythropoiesis, and disruption of this niche can impair red blood cell production. Down-regulation of Myc is required for terminal maturation, and failure of this step can lead to arrested differentiation. The miR-144/451 cluster supports differentiation by inhibiting c-Myc, and its dysregulation may affect enucleation efficiency.
Vel-negative phenotype and SMIM1
SMIM1 missense mutations exert their effect on wild type Vel expression late in erythroid differentiation, a stage that includes enucleation. This links a specific erythroid antigen phenotype to late-stage differentiation events. Studying SMIM1 provides a model for how late differentiation markers can influence terminal maturation.
Anemia and erythropoietin resistance
Beta-adrenergic mechanisms regulate early and late erythropoiesis in erythropoietin-resistant anemia, indicating that stress signals can modulate terminal maturation. Steroids also co-regulate expansion versus terminal differentiation in primary human erythroid progenitors. These findings suggest that positive regulation of enucleation may be relevant to anemias with impaired terminal differentiation.
From positive regulation of erythrocyte enucleation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is MYC down-regulation required for enucleation? | MYC knockout in erythroid progenitors |
| Does miR-144/451 promote enucleation? | miR-144/451 overexpression |
| How do SMIM1 mutations affect late differentiation? | SMIM1 point mutation |
| What is the role of niche adhesion in enucleation? | ITGA4 knockout |
| Can steroid signals enhance terminal differentiation? | Steroid-treated primary erythroid progenitors |
| Do beta-adrenergic signals regulate enucleation? | Beta-adrenergic agonist treatment |
How to Study the positive regulation of erythrocyte enucleation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Enucleated cell frequency | Quantifying enucleation efficiency |
| Imaging | Nuclear expulsion events | Visualizing enucleation |
| RNA-seq | Gene expression changes | Identifying regulators of differentiation |
| MicroRNA profiling | miR-144/451 levels | Post-transcriptional regulation |
| Primary erythroid culture | Terminal differentiation | Testing steroid and adrenergic effects |
| Western blot | Protein expression | Validating MYC down-regulation |
| CRISPR screening | Gene function | Discovering enucleation regulators |
Flow cytometry and imaging of enucleation
Flow cytometry can quantify enucleated cells using nuclear stains, and imaging can visualize nuclear expulsion in real time. These methods are used to assess the efficiency of enucleation in erythroid cultures.
RNA-seq and transcriptomics
RNA-seq measures global gene expression changes during terminal erythropoiesis, including down-regulation of MYC and up-regulation of erythroid genes. This approach helps identify positive regulators of enucleation.
MicroRNA profiling
MicroRNA profiling can detect the miR-144/451 cluster and its targets, providing insight into post-transcriptional regulation of enucleation.
Primary erythroid culture systems
Primary human erythroid progenitors can be expanded and differentiated in vitro, allowing controlled studies of enucleation under different steroid or adrenergic conditions.
How CRISPR Can Be Used to Study GO:0061931 positive regulation of erythrocyte enucleation
Knockout
CRISPR knockout of candidate genes such as MYC or adhesion molecules can test their requirement for enucleation. Knockout of MYC in erythroid progenitors would be expected to impair terminal maturation based on its essential down-regulation. Knockout of ITGA4 or ITGB1 can test the role of erythroblastic island adhesion in enucleation.
Point Mutation
Point mutations can model specific variants such as SMIM1 missense mutations that affect late erythroid differentiation. These models help determine whether a single amino acid change alters enucleation efficiency.
Knock-in
Knock-in of tagged versions of nuclear or cytoskeletal proteins can visualize enucleation dynamics. Knock-in of fluorescent reporters into erythroid genes allows tracking of terminal maturation.
Overexpression
Overexpression of miR-144/451 can test whether increased levels promote enucleation by inhibiting c-Myc. Overexpression of positive regulators may enhance enucleation efficiency in cultured red blood cell production.
How EDITGENE Supports positive regulation of erythrocyte enucleation Research
Researchers studying positive regulation of erythrocyte enucleation-related genes often need to determine whether a candidate gene is causally involved in terminal erythroid maturation. This requires precise genetic models that can knockout, mutate, knock in, or overexpress the gene of interest in erythroid cells. EDITGENE provides these services to accelerate discovery in erythropoiesis research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of erythrocyte enucleation research.
Frequently Asked Questions About positive regulation of erythrocyte enucleation
What is GO:0061931?
GO:0061931 is the Gene Ontology term for positive regulation of erythrocyte enucleation, defined as any process that increases the frequency, rate or extent of erythrocyte enucleation.
What genes are involved in positive regulation of erythrocyte enucleation?
Genes such as MYC, miR-144/451, and SMIM1 are involved in terminal erythroid maturation and enucleation.
How is erythrocyte enucleation regulated?
It is regulated by cell-cycle exit, nuclear condensation, microRNAs like miR-144/451, and niche signals from erythroblastic islands.
Why is enucleation important for red blood cells?
Enucleation allows the erythroblast to become a mature, deformable red blood cell capable of circulating and carrying oxygen.
What diseases are linked to defective enucleation?
Defective enucleation is linked to ineffective erythropoiesis and anemias, including erythropoietin-resistant anemia.
How can I study positive regulation of erythrocyte enucleation?
You can use CRISPR knockout, overexpression, RNA-seq, imaging, and primary erythroid culture systems.
What is the role of MYC in enucleation?
Down-regulation of MYC is essential for terminal erythroid maturation, including enucleation.
What is the role of miR-144/451 in enucleation?
miR-144/451 inhibits c-Myc to promote erythroid differentiation, supporting enucleation.
What are erythroblastic islands?
Erythroblastic islands are specialized niches in the bone marrow that support erythropoiesis, including terminal maturation.
Can cultured red blood cells be used to study enucleation?
Yes, cultured red blood cell systems allow controlled studies of enucleation efficiency and positive regulators.
Conclusion
GO:0061931, positive regulation of erythrocyte enucleation, captures the positive inputs that drive the final step of red blood cell maturation. This process is controlled by cell-cycle exit, microRNAs such as miR-144/451, and niche signals from erythroblastic islands. Understanding these regulators has implications for ineffective erythropoiesis and for the production of cultured red blood cells. Continued research using CRISPR models and transcriptomic methods will further define the molecular players that enhance enucleation.
References
- 2. Chasis JA et al.. 2008. Erythroblastic islands: niches for erythropoiesis.. Blood 112(3):470-8 PMID: 18650462
- 3. Xu L et al.. 2020. miR-144/451 inhibits c-Myc to promote erythroid differentiation.. FASEB J 34(10):13194-13210 PMID: 33319407
- 4. Jayapal SR et al.. 2010. Down-regulation of Myc is essential for terminal erythroid maturation.. J Biol Chem 285(51):40252-65 PMID: 20940306
- 5. van der Rijst MVE et al.. 2021. SMIM1 missense mutations exert their effect on wild type Vel expression late in erythroid differentiation.. Transfusion 61(1):236-245 PMID: 33128268
- 6. Baek EJ et al.. 2010. Enhanced production of red blood cells in suspension by electrostatic interactions with culture plates.. Tissue Eng Part C Methods 16(6):1325-34 PMID: 20302446
- 7. Leberbauer C et al.. 2005. Different steroids co-regulate long-term expansion versus terminal differentiation in primary human erythroid progenitors.. Blood 105(1):85-94 PMID: 15358620
- 8. Hasan S et al.. 2017. Discrete β-adrenergic mechanisms regulate early and late erythropoiesis in erythropoietin-resistant anemia.. Surgery 162(4):901-916 PMID: 28716301
